AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06723197 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Duration of eradication regimen: 14-day
Description: Duration of eradication regimen: 14-day
Study NCT06717672 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine 2% without vessel constrictor
Description: 1. _Lidocaine 2% provides rapid and effective local anesthesia for minor surgical procedures, such as biopsies, excisions, and suturing.~2. _Pain relief_: Lidocaine 2% has been shown to provide significant pain relief in patients with acute pain, such as post-operative pain, trauma, and burns.~3. _Reducing pain intensity_: Lidocaine 2% has been shown to reduce pain intensity by 30-50% in various clinical studies.
Study NCT06717672 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: Normal saline used is an iv fluid given for fluid replacement
Study NCT06704334 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Median nerve electrical stimulation treatment
Description: Median nerve electrical stimulation is an electrical stimulation therapy in which the electrode is placed at the median nerve point 2cm above the carpal wrinkles on the palmar surface of the wrist joint. Generally, the right median nerve is used for electrical stimulation. Electrical stimulation improves cognitive function by stimulating neurons in the brain and improving information transmission between neurons. When electrical current stimulates the brain, it can increase the activity level of neurons and promote the signal transmission between neurons. Its mechanism of action includes the regulation of neurotransmitter acetylcholine, thereby enhancing cognitive function.
Study NCT06704334 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Huperzine A injection
Description: intramuscular
Study NCT06704334 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ginkgo leaf dropping pill
Description: oral
Study NCT06727890 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Danshen Dripping Pill
Description: Danshen Dripping Pill, 10 pills once, three times a day
Study NCT06727890 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, 10 pills once, three times a day
Study NCT06729528 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: The PePCI and ManTIS scores
Description: The PePCI and ManTIS scores have been developed to predict the indication for whole-body CT in pediatric cases presenting to the emergency department with trauma. These scores help reduce unnecessary radiation exposure in pediatric trauma cases.
Study NCT06729827 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hypotension prediction Index - HPI
Description: Patients in the HPI group, in addition to standard monitoring, will have hemodynamic monitoring using HemoSphere (Edwards Lifesciences, Irvine, CA) with ClearSight non-invasive hemodynamic monitoring and with the HPI software enabled.~The patients will be treated with a bolus of norepinephrine 5 mcg each time that HPI is 85 or higher.
Study NCT06729671 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Bifidobacterium longum APC1472 hydroxypropylmethylcellulose (HPMC) capsule
Description: Bifidobacterium longum APC1472 capsule
Study NCT06729671 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: maltodextrin
Description: maltodextrin
Study NCT06729567 — intervention group
Intervention type: OTHER
Intervention: Spinal block level analysis
Description: Relation of the dose of hyperbaric bupivacaine to resulting spinal block level is to be assessed. Conventional dose cases (more than 9mg and less than 13mg) will be included in analysis.
Study NCT06729567 — intervention group
Intervention type: OTHER
Intervention: data collection
Description: Intervention is to acquire and analyse anonymous perioperative data. After identification of the eligible cases, statistical analysis will be performed.
Study NCT06729840 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Injection
Description: Vitamin D , botox , tramcinolone intralesionally injected in keloid
Study NCT06728670 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid Intravenous Infusion
Description: A slow intravenous infusion of 1g TXA was administered at a rate of about 1ml/min.
Study NCT06728670 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TXA intramuscular injection
Description: 5ml intramuscular injections of TXA with twice, each injection time no more than 30 seconds, the injection site was selected as triangle
Study NCT06729047 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal Saline
Description: patients will receive placebo (normal saline)
Study NCT06729047 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine
Description: patients will receive neostigmine (40 μg/kg) plus atropine (20 μg/kg)
Study NCT06729047 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketorolac
Description: patients will receive ketorolac (0.5 mg/kg)
Study NCT06727838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-7535 tablets
Description: HRS-7535 tablets.
Study NCT06727838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin Hydrochloride Extended-release Tablets
Description: Metformin Hydrochloride Extended-release Tablets.
Study NCT06727838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin Hydrochloride Tablets
Description: Metformin Hydrochloride Tablets.
Study NCT06728839 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1L PEG + 50g magnesium sulfate
Description: Subjects in Group A will use a regimen combining magnesium sulfate and polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. 1 litter of polyethylene glycol is taken at 8pm the day before the colonoscopy and 50 gram of magnesium sulfate is taken 4-6 hours before the colonoscopy, and then drink 2000 ml of water within 2 hours.
Study NCT06728839 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3L PEG
Description: Subjects in Group B will use a regimen with 3L polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. The 3 liters of polyethylene glycol solution is taken in split dosing, with 1 liter taken at 8pm the day before the colonoscopy and 2 liters taken 4-6 hours before the colonoscopy.
Study NCT06728839 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 4L PEG
Description: Subjects in Group C will use a regimen with 4L polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. The 4 liters of polyethylene glycol solution is taken in split dosing, with 2 liters taken at 8pm the day before the colonoscopy and 2 liters taken 4-6 hours before the colonoscopy.
Study NCT06729086 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sedation using propofol
Description: The different complications studied will be for example respiratory, neurologic and cardiac based on several clinical and biological parameters.
Study NCT06729086 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sedation using sevoflurane
Description: The differents complications studied will be for example respiratory, neurologic and cardiac based on severl clinical and biological parameters.
Study NCT06729034 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban (Eliquis)
Description: 5 mg twice daily
Study NCT06729034 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo twice daily
Study NCT05939856 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Lymph node dissection before bladder resection
Description: Lymph node dissection before bladder resection
Study NCT05939856 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Lymph node dissection after bladder resection
Description: Lymph node dissection after bladder resection
Study NCT05728866 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: VR immersive therapy
Description: Participants will be asked to participate in 5 consecutive, 1-hour, 1:1 therapy sessions focused on rehabilitation of their weakened arm. Each session will involve use of a Virtual Reality (VR) system to deliver an immersive environment to encourage movement of the arm. The system also relies on 6 body-worn sensors that will detect movements of participant's arms and trunk. VR use will encompass 30-minutes of the therapy session, the remainder of the session will involve working with the therapist in addressing the functional tasks that are most meaningful for the participant and that involve the upper extremities.
Study NCT05621889 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: virtual group speech therapy intervention guided by a patient partner
Description: virtual group speech therapy intervention guided by a patient partner
Study NCT06471439 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: single leg exercise intervantion in COPD
Description: single leg exercise intervantions~1. high intensity interval training~2. continous exercise training~3. resistance exercise training
Study NCT05341024 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle Training in female CrossFit and functional fitness exercisers
Description: The intervention will consist of a home-based PFM training program with weekly follow-up by phone by a physiotherapist. Before commencing PFM training, the participants in the intervention group will have an individual session with a physiotherapist including thorough teaching on how to perform a correct PFM contraction (clinical exams of pelvic floor muscle function by observation and vaginal digital palpation) and instructions on how to perform the training program. The program consists of 3 sets of 8-12 maximum contractions per day. An electronic app (Athlete monitoring) will be used to assess adherence to the program. The participants will be asked to register their training sessions in a personal account. A reminder to adhere to the program will be sent by phone. The training period will be 16 weeks and the exercises will take approximately 10 minutes per day to perform.
Study NCT06506123 — intervention group
Intervention type: DEVICE
Intervention: Artificial Intelligence Detection and Classification of Patient-Ventilator Dyssynchronies
Description: Machine learning algorithm to detect and classify patient-ventilator dyssynchronies, which is integrated in the mechanical ventilator (Fleximag Max, Magnamed, Brazil).
Study NCT05110508 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text Based Behavioral Intervention for Physical Activity
Description: Text intervention messaging will be sent through an automated text messaging service programmed by the CM Informatics team, which has been approved by the institution. Participants will be asked to wear Garmin physical activity monitor to provide physical activity information throughout the intervention. The Garmin is worn like a wristwatch. The device is small and non-intrusive. The Garmin device is a consumer wearable that will automatically detect and track activity such as walking, running, and cycling. The text messages incorporate information from the Garmin monitor to support physical activity.
Study NCT05333497 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: the fourth programmed generation of low-frequency acupoint electric stimulation therapy instrument
Description: Conventional electrical stimulation does not produce coordinated movement of multiple joints by stimulating several locally generated single ones simultaneously. The stimulation after the improved program, through different time output electrical stimulation on different parts of the muscles or muscle groups, forming the programmed motion. The purpose of this study is to achieve the rehabilitation goal of single joint - multiple joint - extensive movement, promote the coordination recovery of affected limb movement and relieve muscle fatigue.
Study NCT05333497 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: the fourth generation of low-frequency acupoint electric stimulation therapy instrument
Description: In this study, the instrument of alternate acupoint electrical stimulation of flexor and extensor muscles combines traditional acupoint therapy with modern low-frequency electric stimulation technology, has the advantages of non-invasive and convenient application, and has a good effect on improving the range of motion of joints, relieving spasm, enhancing muscle strength, promoting the recovery of the central nervous system and other aspects.
Study NCT05417776 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [68Ga]CBP8
Description: An injection of up to 350 MBq of \[68Ga\]CBP8 will be administered intravenously followed by PET-MRI.
Study NCT05417776 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dotarem
Description: Dotarem will be administered during MRI portion of study.
Study NCT04752410 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Selective Brachial Plexus Block
Description: It is one type of peripheral nerve blocks for upper extremity surgery. In this study, the block will be done under the ultrasound guidance and the local anesthetic agent (a mixture of 2% Xylocaine with 1:200,000 adrenaline and 0.5% Chirocaine in a total of 25ml) will be injected at the trunks of the brachial plexus in order to produce the surgical anesthesia of the whole upper extremity of the patients scheduled for upper limb surgeries.
Study NCT06253078 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol dose 0.4mg/Kg
Description: The initial dose of ciprofol was 0.4mg/Kg for induction in this group.
Study NCT06253078 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol dose 0.3mg/Kg
Description: The initial dose of ciprofol was 0.3mg/Kg for induction in this group.
Study NCT06253078 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol dose 0.2mg/Kg
Description: The initial dose of ciprofol was 0.2mg/Kg for induction in this group.
Study NCT05193903 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simulation
Description: The participants in the intervention group receive two interactive simulations in addition to a general text module that provides sequential, animated information on the spread of the virus without prevention, the effectiveness of vaccination and potential side effects of vaccination on a herd protection level and the individual level.
Study NCT05193903 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Text
Description: The participants in the control group receive two text-based information in addition to a general text module that provides information on the spread of the virus without prevention, the effectiveness of vaccination and potential side effects of vaccination on a herd protection level and the individual level.~Both conditions ensure the provision of a level of knowledge that at least corresponds to standard care.
Study NCT04828837 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: bubble PEP
Description: Using the bubble positive expiratory pressure (Bubble PEP) for breathing training of inpatients with COPD. The training course for one day of three times. Every time needs about 20 mins. Huff and cough after the breathing training the end.
Study NCT05139251 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Recovering from Intimate partner violence through Strengths and Empowerment (RISE)
Description: RISE intervention will be implemented for a period of 4 weeks at the beginning of the program. Four components/modules of the RISE intervention which includes a) education on health effects of violence, b) improving coping and self-care, c) enhancing social support, and d) addressing sexual violence will be used. Toward the beginning of each session the participant will complete a brief survey including a 10-item general self-efficacy scale to be graphed and discussed together to provide more immediate feedback to women about their progress, and at times, inform module selection. At the conclusion of each RISE session, women are asked to set a goal related to the topic in consultation with the clinician
Study NCT05139251 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ePALS
Description: Participants and their children will then receive 6 weekly sessions of ePALS. The ePALS sessions include rapport building, recognizing and understanding children's signals, contingently responding to signals, labeling objects and actions, learning book reading strategies, maintaining children's focus of attention, helping children with self-regulation, and language scaffolding techniques. Each parent will have a personal parenting coach who remotely supports their progress through the program.~After a parent views a PALS coaching session, they will videotape themselves trying the strategy for that week with their child. Then their coach sets up a zoom call and together they talk about the PALS strategy and view the video. The coach facilitates parental appraisal of their behavior and discuss what they thought worked with their child and what they want to do differently.
Study NCT05003518 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ParentText
Description: ParentText delivers content, aligning with children's developmental stages (0-23 months, 2-9 years, 10-17 years). ParentText content is delivered through text messages, images, audio and video for parents/ caregivers and their children. Parents receive parenting content surrounding three themes: 1) relationship building by spending time together, 2) positive reinforcement, 3) stress reduction for parents and caregivers. Further supportive content is available for parents of children living with disabilities, child development, online child safety, talking about COVID-19 with children, family budgeting, family harmony, helping with schoolwork and sexual violence prevention.
Study NCT04782440 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitaton
Description: Patients will receive telerehabilitation sessions that include strengthening, stretching and range of motion exercises
Study NCT04782440 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home exercise
Description: Patients will be given a home-based exercise program without telerehabilitation supervision
Study NCT04749251 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Individualized blood pressure management
Description: During the EVT procedure, mean arterial blood pressure (MABP) is targeted to remain within +/- 10 % of a reference value using vasoactive drugs and/or fluids
Study NCT04749251 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard blood pressure management
Description: During the EVT procedure, mean arterial blood pressure (MABP) is targeted to remain within a fixed range of 70-90 mmHg
Study NCT03344276 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Neurocognitive Assessments
Description: Patients will undergo carotid artery stenting for 50-70% carotid artery stenosis. Prior to surgery patients will undergo a battery of neurocogntive assessments 1 month and 2 months prior to surgery.
Study NCT03344276 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Neurocognitive Assessments
Description: Patients will undergo carotid artery stenting for 50-70% carotid artery stenosis. Prior to surgery patients will undergo a battery of neurocogntive assessments 1 month and 2 months prior to surgery.
Study NCT03344276 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Measurements of inflammatory biomarkers
Description: Patients will undergo carotid artery stenting for 50-70% carotid artery stenosis. After surgery, patients will undergo blood draws to measure for inflammatory biomarkers.
Study NCT03344276 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Measurements of inflammatory biomarkers
Description: Patients will undergo carotid artery stenting for 50-70% carotid artery stenosis. After surgery, patients will undergo blood draws to measure for inflammatory biomarkers.
Study NCT03344276 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Carotid Artery Stenting
Description: Patients will undergo carotid artery stenting for 50-70% carotid artery stenosis.
Study NCT05100888 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: repetitive Transcranial Magnetic Stimulation (rTMS)
Description: Theta-burst stimulation
Study NCT05100888 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: repetitive Transcranial Magnetic Stimulation (rTMS)
Description: Theta-burst stimulation
Study NCT05042908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBL-003 Injection
Description: LBL-003 was given every two weeks for treatment
Study NCT05807529 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2ccPA
Description: 2-carba-cyclic phosphatidic acid (2ccPA) is a first-in-class phospholipase autotaxin (ATX) inhibitor that may act as a disease-modifying drug and may relieve OA associated symptoms.~Phase I: 2 dose cohorts (4800μg, 7200μg) single dose at Day 1~Phase II: 3 dose cohorts (2400μg, 4800μg, 7200μg) multiple dose at Day 1, 15, 29
Study NCT05807529 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Phase I: 2 dose cohorts (4800μg, 7200μg) single dose at Day 1~Phase II: 3 dose cohorts (2400μg, 4800μg, 7200μg) multiple dose at Day 1, 15, 29
Study NCT05039216 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood sampling
Description: 4 tubes of 7 mL will be sampled
Study NCT06310356 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Freestyle Libre 3
Description: CGM
Study NCT06310356 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Glucometer
Description: SMBG
Study NCT06161519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PLX038
Description: PLX038 is given intravenously (IV) at the assigned dose level over about 1 hour on day 1 of each 21-day cycle
Study NCT05900180 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Speech Therapy
Description: Delivery of speech therapy services